Preimplantation Genetic Testing Market Forecast and Insights: Exploring Growth Trends, Market Size, and Emerging Opportunities
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Preimplantation Genetic Testing Market?
The preimplantation genetic testing market is expected to grow due to a rise in in vitro fertilization (IVF) procedures. These procedures involve the fertilization of an egg with sperm outside of the body, creating an embryo that is then placed in the uterus. The increase in these procedures is stimulated by advancements in reproductive technology, a surge in infertility rates, and improved public awareness. The escalating demand for genetic screening of embryos before implantation, brought about by the growing number of IVF procedures, is contributing positively to the growth of the preimplantation genetic testing market. In accordance with the Society for Assisted Reproductive Technology, a US-based organization, there were 91,771 babies born via IVF in 2022, as reported in April 2024. This rise in IVF procedures has a direct impact on the expansion of the preimplantation genetic testing market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20596&type=smp
#What Are the Key Projections for the CAGR of the Preimplantation Genetic Testing Market From 2025 to 2034?
Recently, the preimplantation genetic testing market has seen rapid expansion. Its projected growth is from $0.83 billion in 2024 to $0.92 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. Factors contributing to this growth during the historical period include a rise in genetic disorder cases, enhanced awareness about genetic testing, an increase in available prenatal testing options, more demand for personalized medicine, and a growing emphasis on preventive healthcare.
Expectations are high for substantial growth in the preimplantation genetic testing market size in the forthcoming years. The prediction is that it will escalate to $1.41 billion by 2029, with a compound annual growth rate (CAGR) of 11.2%. Factors such as the increasing number of fertility clinics, expansion of genetic counseling services, an upsurge in advanced maternal age, growing accessibility of advanced genetic testing platforms, and widening utilization of PGT, contribute to the growth envisioned in the forecast period. Notable emerging trends for the same period involve the embracement of innovative sequencing technologies, application of broader genetic panels, the emergence of non-invasive testing techniques, progress in embryo culture systems, and improvements in genetic editing technologies.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20596
What Are the Key Market Innovations in thePreimplantation Genetic Testing Market Over the Coming Years?
Leading companies in the preimplantation genetic testing market are innovating in terms of next-generation sequencing (NGS) tools. These tools boost precision, effectiveness and pace in genetic screening, thereby facilitating more in-depth analysis and enabling well-guided choices for prospective parents. NGS tools expedite genetic research through swift, high-throughput study of DNA and RNA. They offer thorough understanding of genetic variations and gene expression, thus improving exactness and promoting personalized medicine. For example, in July 2023, Thermo Fisher Scientific, an American biotechnology firm, introduced the Ion ReproSeq PGT-A Kit and the Ion AmpliSeq Polyploidy Kit. These advanced next-generation sequencing tools have been specifically designed to enhance IVF and ICSI research. These kits streamline procedures from sample handling to aneuploidy analysis with state-of-the-art technology on the Ion torrent genexus integrated sequencer. This move marks a notable progression in the preimplantation genetic testing market as it enhances embryo screening and boosts success rates in assisted reproductive technologies.
Who Are the Top Companies Driving Innovation and Growth in thePreimplantation Genetic Testing Market?
Major companies operating in the preimplantation genetic testing market are Thermo Fisher Scientific, Abbott Laboratories, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Illumina Inc., Revvity Health Science Inc., CooperSurgical Inc., Natera Inc., Progyny Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, Takara Bio Inc., MedGenome Labs Ltd., Genea Limited, Ovation Fertility, Juno Genetics Ltd., Invicta Genetics, Progenesis, Bioarray SL, PacGenomics, Reproductive Genetic Innovations LLC, SEQUENCE46 LLC
Order Your Report Now For A Swift Delivery:
Which Key Market Segments Comprise the Preimplantation Genetic Testing Market and Drive Its Revenue Growth?
The preimplantation genetic testing market covered in this report is segmented –
1) By Procedure: Preimplantation Genetic Screening, Preimplantation Genetic Diagnosis
2) By Product: Reagents And Consumables, Instruments, Software
3) By Technology: Next Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescent In Situ Hybridization (FISH), Other Technologies
4) By Application: Chromosomal Abnormalities, Aneuploidy Screening, X-Linked Diseases, Embryo Testing, Human Leukocyte Antigen (HLA) Typing, Other Applications
5) By End User: Hospitals, Fertility Centers, Diagnostic Centers, Research Centers And Academic Labs
Subsegments:
1) By Preimplantation Genetic Screening (PGS): Array Comparative Genomic Hybridization (aCGH), Next-Generation Sequencing (NGS), Fluorescence In Situ Hybridization (FISH)
2) By Preimplantation Genetic Diagnosis (PGD): Monogenic Disorders Testing, Chromosomal Abnormalities Testing, HLA Typing for Stem Cell Transplantation
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=20596&type=smp
Which Regions Are Emerging as Leaders in the Preimplantation Genetic Testing Market?
North America was the largest region in the preimplantation genetic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the preimplantation genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Preimplantation Genetic Testing Market 2025, By The Business Research Company:
Direct-To-Consumer (Dtc) Genetic Testing Global Market Report 2025
Genetically Modified Fruits Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/genetically-modified-fruits-global-market-report
Optogenetics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/optogenetics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
